AAV9-follistatin therapy (Milo)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAAV9-follistatin therapy (Milo)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGrowth/differentiation factor 8 inhibitors
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsAtrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNationwide Children'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMilo Biotechnology
Active IndicationsN/A
Inactive IndicationsAtrophy

Other Information

ATC CodeN/A
Related LinksN/A